Collegium Pharmaceutical Inc reports results for the quarter ended in September - Earnings Summary

Collegium Pharmaceutical

03/11/2022 21:02

* Collegium Pharmaceutical Inc  COLL.OQ  reported quarterly
adjusted earnings of 1 cent​​ per share for the quarter ended in
September. The mean expectation of seven analysts for the
quarter was for a loss of 13 cents per share.
    * Revenue rose 61.1% to $127.01 million from a year ago;
analysts
expected $124.33 million. 
    * Collegium Pharmaceutical Inc's reported EPS for the
quarter was
1 cent​.
    * The mean earnings estimate of analysts had fallen by
about 112.8% in the last three months.​ 
    * In the last 30 days two analysts negatively revised
earnings
estimates 
    * Collegium Pharmaceutical Inc shares had risen by 10.0%
this
quarter and lost 5.6% so far this year.
    * The company reported quarterly net income of $457
thousand.
    * Wall Street's median 12-month price target for Collegium
Pharmaceutical Inc is $36.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 6 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 

This summary was machine generated from Refinitiv data November
3 at 09:02 p.m.  ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2022      -0.13          0.01           Beat
 Jun. 30 2022      1.42           0.32           Missed
 Mar. 31 2022      0.90           0.44           Missed
 Dec. 31 2021      1.04           -0.51          Missed